0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Ramesh B. Batchu, PhD; Oksana Gruzdyn, BS; Ravindra B. Potti, PhD; et al.
JAMA Surg. 2014;149(5):451-457. doi:10.1001/jamasurg.2013.4113.

Invited Commentary | 
David H. Berger, MD, MHCM
JAMA Surg. 2014;149(5):457-458. doi:10.1001/jamasurg.2013.4163.

Invited Critique | 
Ronan Cahill, MD
JAMA Surg. 2013;148(3):231. doi:10.1001/jamasurg.2013.703.

Review Article |  FREE
Kevin P. Charpentier, MD
Arch Surg. 2012;147(11):1053-1061. doi:10.1001/2013.jamasurg.100.

Invited Critique | 
Steven D. Colquhoun, MD
Arch Surg. 2012;147(11):1061. doi:10.1001/jamasurg.2013.493.

Paper |  FREE
Daniel Vallböhmer, MD; Jeffrey H. Peters, MD; Hidekazu Kuramochi, MD; et al.
Arch Surg. 2006;141(5):476-482. doi:10.1001/archsurg.141.5.476.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Lab Reports  | 
Investigational Drug May Fight Asbestos-Related Cancer
Tracy Hampton, PhD
JAMA
Original Investigation  | 
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib:  The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu, MD, PhD; Masatoshi Kudo, MD, PhD; Eric Assenat, MD, PhD; et al.
JAMA Internal Medicine
Special Communication  | 
A Guide to Reading Health Care News Stories
Gary Schwitzer, BA
JAMA
Health Agencies Update  | 
Use of Immunotherapy for Gastrointestinal Cancers
Bridget M. Kuehn, MSJ